Kolium Tab 300 mg Tablet is a Health Canada–registered human drug (DIN 00510815) held by Nobel Pharm Enr., containing Choline Dihydrogen Citrate. Health Canada lists its status as Cancelled Post Market (status date 15 Oct 2001). Nexara Health has matched 2 registrations of Choline Dihydrogen Citrate across 1 other regulated market.
Health Canada registration
| DIN | 00510815 |
|---|---|
| Brand name | Kolium Tab |
| Active ingredient | Choline Dihydrogen Citrate |
| Strength | 300 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Nobel Pharm Enr. |
| Status | Cancelled Post Market — 15 Oct 2001 |
| Class | Human |
| ATC | |
| AHFS | 88:28.01* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Choline Dihydrogen Citrate registered in other markets
2 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Choline Dihydrogen Citrate | Lederle Pharmaceutical Division Of American Cyanamid Company | （粉） | 已註銷 | TFDA | |
| Taiwan | Choline Dihydrogen Citrate "E.merck" | MERCK KGaA | （粉） | 已註銷 | TFDA |
See every manufacturer of Choline Dihydrogen Citrate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Kolium Tab (DIN 00510815) marketed in Canada?
No. Health Canada lists DIN 00510815 as Cancelled Post Market as of 15 Oct 2001.
Who holds the Canadian licence for this product?
Nobel Pharm Enr. is the company of record in the Health Canada Drug Product Database.
Is Choline Dihydrogen Citrate registered outside Canada?
Yes — Nexara Health has matched 2 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00510815, status date 2001-10-15; national medicine registries: TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00510815, status date 2001-10-15; national medicine registries: TFDA.
Health Canada Drug Product Database (DPD), DIN 00510815, status date 2001-10-15; national medicine registries: TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.